199 related articles for article (PubMed ID: 32500484)
1. Hidradenitis Suppurativa and Concurrent Psoriasis: Comparison of Epidemiology, Comorbidity Profiles, and Risk Factors.
Pinter A; Kokolakis G; Rech J; Biermann MHC; Häberle BM; Multmeier J; Reinhardt M
Dermatol Ther (Heidelb); 2020 Aug; 10(4):721-734. PubMed ID: 32500484
[TBL] [Abstract][Full Text] [Related]
2. Coprevalence of Hidradenitis Suppurativa and Psoriasis: Detailed Demographic, Disease Severity and Comorbidity Pattern.
Pinter A; Sarlak M; Zeiner KN; Malisiewicz B; Kaufmann R; Romanelli M; Koenig A; Chiricozzi A
Dermatology; 2021; 237(5):759-768. PubMed ID: 33326954
[TBL] [Abstract][Full Text] [Related]
3. Psoriasis as a comorbidity of hidradenitis suppurativa.
Kjaersgaard Andersen R; Saunte SK; Jemec GBE; Saunte DM
Int J Dermatol; 2020 Feb; 59(2):216-220. PubMed ID: 31591714
[TBL] [Abstract][Full Text] [Related]
4. Treatment Patterns and Healthcare Resource Utilization Among Newly Diagnosed Psoriasis, Psoriatic Arthritis, Axial Spondyloarthritis, and Hidradenitis Suppurativa Patients with Past Diagnosis of an Inflammatory Condition: A Retrospective Cohort Analysis of Claims Data in the United States.
Hopson S; Gibbs LR; Syed S; Low R; McClung L; Beaty S
Adv Ther; 2023 Oct; 40(10):4358-4376. PubMed ID: 37486558
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and comorbidity of hidradenitis suppurativa in Korea for 17 years: A nationwide population-based cohort study.
Lee JW; Heo YW; Lee JH; Lee S
J Dermatol; 2023 Jun; 50(6):778-786. PubMed ID: 36806098
[TBL] [Abstract][Full Text] [Related]
6. Hidradenitis suppurativa is a systemic disease with substantial comorbidity burden: a chart-verified case-control analysis.
Shlyankevich J; Chen AJ; Kim GE; Kimball AB
J Am Acad Dermatol; 2014 Dec; 71(6):1144-50. PubMed ID: 25440440
[TBL] [Abstract][Full Text] [Related]
7. Risk of cardiovascular disorders in hidradenitis suppurativa patients: a large-scale, propensity-matched global retrospective cohort study.
Krajewski PK; Matusiak Ł; Ständer S; Thaçi D; Szepietowski JC; Zirpel H
Int J Dermatol; 2024 Jun; 63(6):799-805. PubMed ID: 38644522
[TBL] [Abstract][Full Text] [Related]
8. Risk of psoriasis in people with hidradenitis suppurativa: A systematic review and meta-analysis.
Gau SY; Preclaro IAC; Wei JC; Lee CY; Kuan YH; Hsiao YP; Juang SE; Ma KS
Front Immunol; 2022; 13():1033844. PubMed ID: 36532043
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of hidradenitis suppurativa in Taiwan: A 14-year nationwide population-based study.
Liang YT; Yeh CJ; Huang JY; Wei JC
J Dermatol; 2021 May; 48(5):613-619. PubMed ID: 33626195
[TBL] [Abstract][Full Text] [Related]
10. Psoriasis and hidradenitis suppurativa: A large-scale population-based study.
Kridin K; Shani M; Schonmann Y; Fisher S; Shalom G; Comaneshter D; Batat E; Cohen AD
J Am Acad Dermatol; 2023 May; 88(5):e231-e236. PubMed ID: 30502412
[TBL] [Abstract][Full Text] [Related]
11. Association of metabolic syndrome and hidradenitis suppurativa.
Miller IM; Ellervik C; Vinding GR; Zarchi K; Ibler KS; Knudsen KM; Jemec GB
JAMA Dermatol; 2014 Dec; 150(12):1273-80. PubMed ID: 25229996
[TBL] [Abstract][Full Text] [Related]
12. Increased risk of cardiovascular comorbidities in hidradenitis suppurativa: A nationwide, population-based, cohort study in Taiwan.
Hung CT; Chiang CP; Chung CH; Tsao CH; Chien WC; Wang WM
J Dermatol; 2019 Oct; 46(10):867-873. PubMed ID: 31389066
[TBL] [Abstract][Full Text] [Related]
13. Decreased Arterial Vascular Tone in Small Arteries in Severe Hidradenitis Suppurativa - A Study Using Finger Photopulseplethysmography.
Miller IM; Ahlehoff O; Zarchi K; Rytgaard H; Mogensen UB; Ellervik C; E Jemec GB
Acta Dermatovenerol Croat; 2022 Sep; 30(2):119-122. PubMed ID: 36254547
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and comorbidities associated with hidradenitis suppurativa in Korea: a nationwide population-based study.
Lee JH; Kwon HS; Jung HM; Kim GM; Bae JM
J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1784-1790. PubMed ID: 29761904
[TBL] [Abstract][Full Text] [Related]
15. Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis.
Scheinfeld N
Dermatol Online J; 2013 Jun; 19(6):18558. PubMed ID: 24011308
[TBL] [Abstract][Full Text] [Related]
16. The Prevalent Comorbidome at the Onset of Psoriasis Diagnosis.
Buja A; Miatton A; Cozzolino C; Brazzale AR; Lo Bue R; Mercuri SR; Proft FN; Kridin K; Cohen AD; Damiani G
Dermatol Ther (Heidelb); 2023 Sep; 13(9):2093-2105. PubMed ID: 37542678
[TBL] [Abstract][Full Text] [Related]
17. Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa.
Miller IM; McAndrew RJ; Hamzavi I
Dermatol Clin; 2016 Jan; 34(1):7-16. PubMed ID: 26617352
[TBL] [Abstract][Full Text] [Related]
18. Recommendations for the management of comorbidity in hidradenitis suppurativa.
Dauden E; Lazaro P; Aguilar MD; Blasco AJ; Suarez C; Marin I; Queiro R; Bassas-Vila J; Martorell A; García-Campayo J
J Eur Acad Dermatol Venereol; 2018 Jan; 32(1):129-144. PubMed ID: 28796920
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of comorbidities in atopic dermatitis and psoriasis in the French population.
Richard MA; Sei JF; Philippe C; Taieb C; Joly P; Ezzedine K
Ann Dermatol Venereol; 2021 Mar; 148(1):28-33. PubMed ID: 33500190
[TBL] [Abstract][Full Text] [Related]
20. Hidradenitis suppurativa: Epidemiology and scope of the problem.
Jemec GB; Kimball AB
J Am Acad Dermatol; 2015 Nov; 73(5 Suppl 1):S4-7. PubMed ID: 26470614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
